Literature DB >> 19430451

Targeted instant immunity.

Claude F Meares.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19430451     DOI： 10.1038/nbt0509-452

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  8 in total

1.  Chemically programmed monoclonal antibodies for cancer therapy: adaptor immunotherapy based on a covalent antibody catalyst.

Authors:  Christoph Rader; Subhash C Sinha; Mikhail Popkov; Richard A Lerner; Carlos F Barbas
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-17       Impact factor: 11.205

2.  Design and synthesis of alpha Gal-conjugated peptide T20 as novel antiviral agent for HIV-immunotargeting.

Authors:  Kannan P Naicker; Hengguang Li; Alonso Heredia; Haijing Song; Lai-Xi Wang
Journal:  Org Biomol Chem       Date:  2004-02-02       Impact factor: 3.876

3.  Chemically programmed antibodies: endothelin receptor targeting CovX-Bodies.

Authors:  Venkata R Doppalapudi; Nancy Tryder; Lingna Li; Teresa Aja; David Griffith; Francesca-Fang Liao; Giovanni Roxas; Mysore P Ramprasad; Curt Bradshaw; Carlos F Barbas
Journal:  Bioorg Med Chem Lett       Date:  2006-10-07       Impact factor: 2.823

4.  Instant immunity through chemically programmable vaccination and covalent self-assembly.

Authors:  Mikhail Popkov; Beatriz Gonzalez; Subhash C Sinha; Carlos F Barbas
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

5.  Breaking the one antibody-one target axiom.

Authors:  Fang Guo; Sanjib Das; Barbara M Mueller; Carlos F Barbas; Richard A Lerner; Subhash C Sinha
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-05       Impact factor: 11.205

6.  Small molecule drug activity in melanoma models may be dramatically enhanced with an antibody effector.

Authors:  Mikhail Popkov; Christoph Rader; Beatriz Gonzalez; Subhash C Sinha; Carlos F Barbas
Journal:  Int J Cancer       Date:  2006-09-01       Impact factor: 7.396

7.  Chemical adaptor immunotherapy: design, synthesis, and evaluation of novel integrin-targeting devices.

Authors:  Lian-Sheng Li; Christoph Rader; Masayuki Matsushita; Sanjib Das; Carlos F Barbas; Richard A Lerner; Subhash C Sinha
Journal:  J Med Chem       Date:  2004-11-04       Impact factor: 7.446

8.  Folate targeting of haptens to cancer cell surfaces mediates immunotherapy of syngeneic murine tumors.

Authors:  Yingjuan Lu; Philip S Low
Journal:  Cancer Immunol Immunother       Date:  2002-03-19       Impact factor: 6.968
  8 in total
  1 in total

Review 1.  Chemically modified antibodies as diagnostic imaging agents.

Authors:  Jeffrey J Day; Bernadette V Marquez; Heather E Beck; Tolulope A Aweda; Prasad D Gawande; Claude F Meares
Journal:  Curr Opin Chem Biol       Date:  2010-10-15       Impact factor: 8.822
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.